Cargando…
Preemptive versus postoperative lumiracoxib for analgesia in ambulatory arthroscopic knee surgery
We compared the efficacy and safety of preemptive vs postoperative dosing of lumiracoxib 400 mg in patients undergoing minor ambulatory arthroscopic knee surgery. Eligible patients were randomized to preemptive lumiracoxib, postoperative lumiracoxib, and placebo. The main efficacy parameter was pain...
Autores principales: | Grifka, Joachim, Enz, Rudolf, Zink, Joachim, Hugot, Jean Louis, Kreiss, Andreas, Arulmani, Udayasankar, Yu, Vincent, Rebuli, Rosemary, Krammer, Gerhard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004612/ https://www.ncbi.nlm.nih.gov/pubmed/21197285 |
Ejemplares similares
-
Preemptive Analgesia Does Not Reduce Pain or Improve Postoperative Functioning
por: Grube, Jennifer O., et al.
Publicado: (2004) -
Etoricoxib - preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy - design and protocols
por: Fleckenstein, Johannes, et al.
Publicado: (2010) -
Preemptive analgesia with intra-articular pethidine reduces pain after arthroscopic knee surgery
por: Hashemi, Sayed Jalal, et al.
Publicado: (2013) -
Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis
por: Profit, Louise, et al.
Publicado: (2007) -
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
por: Stricker, Kirstin, et al.
Publicado: (2008)